| dc.contributor.author |
Anova, Health Institute |
|
| dc.date.accessioned |
2024-09-13T07:45:56Z |
|
| dc.date.available |
2024-09-13T07:45:56Z |
|
| dc.date.issued |
2024-08 |
|
| dc.identifier.uri |
http://hdl.handle.net/123456789/1592 |
|
| dc.description |
REPORT ON THE PROGRAMME OF SCIENCE IN ACTION |
en_US |
| dc.description.sponsorship |
USAID, PEPFAR |
en_US |
| dc.language.iso |
en_US |
en_US |
| dc.subject |
HIV |
en_US |
| dc.subject |
TB |
en_US |
| dc.subject |
ART |
en_US |
| dc.subject |
Viral Suppression |
en_US |
| dc.subject |
Priority Populations |
en_US |
| dc.title |
PROGRAMME SCIENCE IN ACTION: Insights from Anova’s HIV & TB programmes |
en_US |
| dc.type |
Article |
en_US |